{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:40:30Z","timestamp":1760082030483,"version":"build-2065373602"},"reference-count":17,"publisher":"Jaypee Brothers Medical Publishing","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.59556\/japi.73.1033","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:26:10Z","timestamp":1760081170000},"page":"64-67","source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Analysis of Sepsis Outcomes in Patients with Autoimmune Diseases: Sequential Organ Failure Assessment Scores, Mortality, and Disease Response"],"prefix":"10.59556","volume":"73","author":[{"given":"Ram","family":"Bhat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarsh","family":"Sangathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(1):","key":"key20251010072601_B1","doi-asserted-by":"crossref","first-page":"23\u2013","DOI":"10.1172\/JCI82224","article-title":"Sepsis-induced immune dysfunction: can immune therapies reduce mortality?","volume":"126","author":"Delano","year":"2016;","journal-title":"J Clin Invest"},{"issue":"(9):","key":"key20251010072601_B2","doi-asserted-by":"crossref","first-page":"840\u2013","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock.","volume":"369","author":"Angus","year":"2013;","journal-title":"N Engl J Med"},{"issue":"(3):","key":"key20251010072601_B3","doi-asserted-by":"crossref","first-page":"259\u2013","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations.","volume":"193","author":"Fleischmann","year":"2016;","journal-title":"Am J Respir Crit Care Med"},{"issue":"(5):","key":"key20251010072601_B4","doi-asserted-by":"crossref","first-page":"1649\u2013","DOI":"10.1097\/CCM.0b013e31819def97","article-title":"The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation.","volume":"37","author":"Jones","year":"2009;","journal-title":"Crit Care Med"},{"issue":"(8):","key":"key20251010072601_B5","doi-asserted-by":"crossref","first-page":"801\u2013","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3).","volume":"315","author":"Singer","year":"2016;","journal-title":"JAMA"},{"key":"key20251010072601_B6","doi-asserted-by":"crossref","first-page":"387.","DOI":"10.3389\/fimmu.2013.00387","article-title":"Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.","volume":"4:","author":"Savva","year":"2013;","journal-title":"Front Immunol"},{"issue":"(7):","key":"key20251010072601_B7","doi-asserted-by":"crossref","first-page":"407\u2013","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets.","volume":"17","author":"van der Poll","year":"2017;","journal-title":"Nat Rev Immunol"},{"issue":"(Suppl 5):","key":"key20251010072601_B8","first-page":"661\u2013","article-title":"Introduction to immunology and autoimmunity.","volume":"107","author":"Smith","year":"1999;","journal-title":"Environ Health Perspect"},{"key":"key20251010072601_B9","volume-title":"Infection and autoimmune diseases. Autoimmunity: From Bench to Bedside.","author":"Arango","year":"2013."},{"key":"key20251010072601_B10","doi-asserted-by":"crossref","first-page":"e070856.","DOI":"10.1136\/bmj-2022-070856","article-title":"Therapeutic advances in rheumatoid arthritis.","volume":"384:","author":"Brown","year":"2024;","journal-title":"BMJ"},{"key":"key20251010072601_B11","doi-asserted-by":"crossref","first-page":"925\u2013","DOI":"10.1136\/annrheumdis-2021-221957","article-title":"Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial.","volume":"81:","author":"Boers","year":"2022;","journal-title":"Ann Rheum Dis"},{"key":"key20251010072601_B12","doi-asserted-by":"crossref","first-page":"165974.","DOI":"10.1155\/2013\/165974","article-title":"Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2014an updated view.","volume":"2013:","author":"Schulte","year":"2013;","journal-title":"Mediators Inflamm"},{"issue":"(2):","key":"key20251010072601_B13","doi-asserted-by":"crossref","first-page":"128\u2013","DOI":"10.1097\/SHK.0000000000000742","article-title":"Severe sepsis outcomes among hospitalizations with inflammatory bowel disease.","volume":"47","author":"Colbert","year":"2017;","journal-title":"Shock"},{"issue":"(5):","key":"key20251010072601_B14","first-page":"e8094.","article-title":"The prevalence of autoimmune disorders in women: a narrative review.","volume":"12","author":"Angum","year":"2020;","journal-title":"Cureus"},{"key":"key20251010072601_B15","doi-asserted-by":"crossref","first-page":"93.","DOI":"10.1186\/s13054-019-2357-1","article-title":"The association between autoimmune disease and 30-day mortality among sepsis ICU patients: a cohort study.","volume":"23:","author":"Sheth","year":"2019;","journal-title":"Crit Care"},{"key":"key20251010072601_B16","doi-asserted-by":"crossref","first-page":"476.","DOI":"10.1186\/s13054-023-04763-5","article-title":"Association of autoimmune diseases with the occurrence and 28-day mortality of sepsis: an observational and Mendelian randomization study.","volume":"27:","author":"Li","year":"2023;","journal-title":"Crit Care"},{"issue":"(9):","key":"key20251010072601_B17","doi-asserted-by":"crossref","first-page":"1667\u2013","DOI":"10.1136\/annrheumdis-2015-207838","article-title":"Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis.","volume":"75","author":"Richter","year":"2016;","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:26:14Z","timestamp":1760081174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-73-7-64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.59556\/japi.73.1033"],"URL":"https:\/\/doi.org\/10.59556\/japi.73.1033","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}